The Cooper Companies (NYSE:COO) Has Just Had Its Target Diminished by Equity Research Analysts at Robert W. Baird to $155.00

Share

Analysis: The Cooper Companies (NYSE:COO) Upside Target Change Today

In an analyst research report finalized by Robert W. Baird on Friday, 4 December, the firm, The Cooper Companies (NYSE:COO), had their price target lowered to $155.00. Analusts at present have a solid Outperform rating on the stock.

From a total of 11 analysts covering Cooper (NYSE:COO) stock, 10 rate it a ”Buy”, 0 a “Sell”, and 4 a ”Hold”. This means that 71% of the ratings are positive. The highest target price is $183 while the lowest target price is $136. The mean of all analyst targets is $158.64 with a 29.91% above today’s ($130.34) stock price. Cooper was the topic of 11 analyst reports since August 26, 2015 according to the firm StockzIntelligence Inc. Piper Jaffray maintained shares on December 4 with “Overweight” rating. KeyBanc Capital Markets upgraded shares to “Sector Weight” rating and $200.0 target share price in a report from an August 26. Wells Fargo downgraded COO stock in a recent report from November 17 to “Market Perform” rating. Finally, Zacks downgraded the stock to “Hold” rating in a report issued on an August 31.

The stock decreased 8.20% or $11.65 on December 4, striking $130.34. Approximately shares of stock traded hands. Cooper Companies Inc (NYSE:COO) has declined 27.22% since May 4, 2015 and is downtrending. It has underperformed by 26.14% the S&P500.

The Cooper Companies, Inc. , is a global medical device company. The company has a market cap of $6.34 billion. The Firm operates through two business units, CooperVision, Inc. (CVI) and CooperSurgical, Inc. (CSI). It has 32.45 P/E ratio. CooperVision is a global maker providing products for contact lens wearers.

According to Zacks Investment Research, “The Cooper Companies, Inc., through its principal subsidiaries, develops, manufactures and markets healthcare products. CooperVision markets a range of contact lenses to correct visual defects, specializing in toric lenses that correct astigmatism. The company also markets conventional toric and spherical lenses and lenses for patients with more complex vision disorders. CooperSurgical markets diagnostic products, surgical instruments and accessories to the women’s healthcare market.” Get a free copy of the Zacks research report on Cooper Companies Inc (COO).

COMMENTS: